Safe substitution for efavirenz.
D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects*; D048588:Benzoxazines; D002493:Central Nervous System Diseases / Q000139:chemically induced*; D003521:Cyclopropanes; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced*; D019829:Nevirapine / Q000627:therapeutic use*; D010078:Oxazines / Q000009:adverse effects*; D018579:Patient Selection; D012189:Retrospective Studies; D016896:Treatment Outcome; D019562:Viral Load
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D019829:Nevirapine; C098320:efavirenz